LONDON, July 9 (Reuters) - GlaxoSmithKline Plc has won a licence extension in Europe for Seretide, allowing its top-selling inhaler product to be used in a wider population of patients with the lung ...
(Reuters) - GlaxoSmithKline Plc said on Wednesday the U.S health regulator approved its lung disease drug Trelegy Ellipta for expanded use, making it the first inhaler delivering three drugs at once ...
Add Yahoo as a preferred source to see more of our stories on Google. Sodiq Ajibade, 29, who suffers from bouts of asthma attacks, speaks to a pharmacist about the Seretide inhaler at a pharmacy in ...
GlaxoSmithKline Plc said on Wednesday the U.S health regulator approved its lung disease drug Trelegy Ellipta for expanded use, making it the first inhaler delivering three drugs at once to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results